BioGaia AB (publ) (LON:0GTN)

London flag London · Delayed Price · Currency is GBP · Price in SEK
100.30
-1.00 (-0.99%)
At close: Jun 19, 2025
-19.70%
Market Cap 766.77M
Revenue (ttm) 109.43M
Net Income (ttm) 23.88M
Shares Out n/a
EPS (ttm) 0.24
PE Ratio 32.11
Forward PE n/a
Dividend 0.54 (0.53%)
Ex-Dividend Date May 8, 2025
Volume 1,566
Average Volume 11,984
Open 99.55
Previous Close 101.30
Day's Range 99.30 - 100.50
52-Week Range 93.63 - 135.40
Beta 0.62
RSI 44.17
Earnings Date Jul 18, 2025

About BioGaia AB

BioGaia AB (publ), a healthcare company, provides probiotic products worldwide. The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula and milk formula. The Adult Health segment provides gut health tablets, bone health tablets and oral health lozenges, as well as cultures, which are used as an ingredient in a licensee’s dairy product. The Other segment provides packagin... [Read more]

Industry Pharmaceutical Preparations
Founded 1990
Employees 225
Stock Exchange London Stock Exchange
Ticker Symbol 0GTN
Full Company Profile

Financial Performance

In 2024, BioGaia AB's revenue was 1.42 billion, an increase of 9.73% compared to the previous year's 1.30 billion. Earnings were 351.39 million, a decrease of -3.82%.

Financial numbers in SEK Financial Statements

News

There is no news available yet.